| Patient | Albert Einstein |
|---|---|
| Date of birth | 1956-03-14 |
| Identifiers | MRN HR-ET012-SYN; SSN (made up) 000-12-6650 |
| Document date | 2026-03-24 |
| Author | Clementine Ward, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Establishing care for a known abdominal aortic aneurysm: duplex ultrasound, blood pressure, lipids, smoking, and emergency symptoms [S]
This fictional modern episode addresses the presenting concerns below. [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
4 later historical claims are omitted because they describe events after the index age. See the teaching note.
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| 1948 | Intermittent severe abdominal pain, at times with vomiting, worse toward the end of the year | D (CLM-0004) |
| December 31, 1948 | Exploratory laparotomy: a large abdominal aortic aneurysm was found; it could not be removed, and its front was wrapped in cellophane to provoke scarring; discharged about three weeks later | D (CLM-0005, CLM-0006) |
No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Amlodipine 5 mg oral tablet, one tablet daily | One tablet by mouth each morning | Oral route | 2025-05-20 | active | S |
| Losartan 50 mg oral tablet, one tablet daily | One tablet by mouth each morning | Oral route | 2026-03-24 to 2026-04-21 | completed | S |
| Atorvastatin 40 mg oral tablet, one tablet daily | One tablet by mouth each evening | Oral route | 2026-03-24 | active | S |
| Nicotine 14 mg/24 hour transdermal patch, one patch daily | Apply one new patch each morning | Topical route | 2026-03-24 to 2026-07-14 | completed | S |
| Nicotine 2 mg lozenge as needed for cravings | Dissolve one lozenge in the mouth for a craving, no more often than every 2 hours and no more than 20 a day | Oral route | 2026-03-24 to 2026-09-22 | completed | S |
Positive for the concerns in the history of present illness. Alert, curious, and direct; asks for exact figures and the evidence behind them; mood good. No other systems reported as affected in this synthetic episode. [S]
Alert and engaged. Independent in all activities of daily living and instrumental activities; no falls. [S]
Vital signs recorded on 2026-03-24; see the Vital Signs section. Mental status: Alert, curious, and direct; asks for exact figures and the evidence behind them; mood good. The physical examination is limited to the findings relevant to this synthetic episode. [S]
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-03-24 | Body height | 172 | cm | S |
| 2026-03-24 | Body weight | 79 | kg | S |
| 2026-03-24 | Body mass index (BMI) [Ratio] | 26.7 | kg/m2 | S |
| 2026-03-24 | Systolic blood pressure | 146 | mm[Hg] | S |
| 2026-03-24 | Diastolic blood pressure | 86 | mm[Hg] | S |
| 2026-03-24 | Heart rate | 72 | /min | S |
| 2026-03-24 | Respiratory rate | 14 | /min | S |
| 2026-03-24 | Body temperature | 36.7 | Cel | S |
| 2026-03-24 | Oxygen saturation in Arterial blood by Pulse oximetry | 96 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-03-24 | Aorta Diameter by US | 5 | cm | <=3 cm | High | S |
| 2026-03-24 | Hemoglobin [Mass/volume] in Blood | 14.2 | g/dL | 13.2-16.6 g/dL | Normal | S |
| 2026-03-24 | Leukocytes [#/volume] in Blood by Automated count | 7.4 | 10*3/uL | 3.4-9.6 10*3/uL | Normal | S |
| 2026-03-24 | Platelets [#/volume] in Blood by Automated count | 232 | 10*3/uL | 135-317 10*3/uL | Normal | S |
| 2026-03-24 | Sodium [Moles/volume] in Serum or Plasma | 140 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-03-24 | Potassium [Moles/volume] in Serum or Plasma | 4.3 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-03-24 | Creatinine [Mass/volume] in Serum or Plasma | 1.02 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 2026-03-24 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 77 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-03-24 | Glucose [Mass/volume] in Serum or Plasma | 98 | mg/dL | 70-99 mg/dL | Normal | S |
| 2026-03-24 | Calcium [Mass/volume] in Serum or Plasma | 9.4 | mg/dL | 8.6-10.3 mg/dL | Normal | S |
| 2026-03-24 | Cholesterol [Mass/volume] in Serum or Plasma | 216 | mg/dL | <=200 mg/dL | High | S |
| 2026-03-24 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 44 | mg/dL | >=40 mg/dL | Normal | S |
| 2026-03-24 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 142 | mg/dL | <=129 mg/dL | High | S |
| 2026-03-24 | Triglyceride [Mass/volume] in Serum or Plasma | 148 | mg/dL | <=149 mg/dL | Normal | S |
| 2026-03-24 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.6 | % | <=5.6% | Normal | S |
| 2026-03-24 | Albumin/Creatinine [Mass Ratio] in Urine | 14 | mg/g{creat} | <=30 mg/g{creat} | Normal | S |
| 2026-03-24 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 24 | U/L | 7-55 U/L | Normal | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Infrarenal abdominal aortic aneurysm, 5.0 cm by duplex ultrasound, found and wrapped at a prior exploratory laparotomy; under surveillance below the repair threshold | active | confirmed | I71.43 | S — Synthetic modern coding anchored to the documented aneurysm found and wrapped at his exploratory laparotomy; the diameter and all surveillance are synthetic. |
| Essential hypertension | active | confirmed | I10 | S — Synthetic risk factor in the modern frame; no historical blood pressure is documented in the cited sources. |
| Nicotine dependence, pipe tobacco | active | confirmed | F17.290 | S — Synthetic modern coding anchored to his documented pipe smoking. |